Justin M Gregory

19PUBLICATIONS
18CO-AUTHORS
Molecular targetsAnimal growth and developmentInfant and child healthPharmaceutical delivery technologiesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 22, 2024
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.

Schafer C Boeder, Robert L Thomas, Melissa J Le Roux

|Dec 22, 2023
A high-fat and fructose diet in dogs mirrors insulin resistance and β-cell dysfunction characteristic of impaired glucose tolerance in humans.

Justin M Gregory, Guillaume Kraft, Chiara Dalla Man

|Aug 09, 2022
COVID-19 Exacerbates Insulin Resistance During Diabetic Ketoacidosis in Pediatric Patients With Type 1 Diabetes.

Elizabeth S Keiner, James C Slaughter, Karishma A Datye

|Apr 20, 2022
A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication.

Sérgio Vencio, Rafael Caiado-Vencio, Leonardo Ferreira Caixeta

|Dec 03, 2021
SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes.

Schafer C Boeder, Justin M Gregory, Erin R Giovannetti

|Jun 16, 2021
Insulin Infusion Is Linked to Increased NPPC Expression in Muscle and Plasma C-type Natriuretic Peptide in Male Dogs.

Justin M Gregory, Guillaume Kraft, Ben Farmer

Pageof 4

Frequent Collaborators

3 joint publications

Schafer C Boeder

3 joint publications

Jeremy H Pettus

2 joint publications

Sarah S Jaser

2 joint publications

Daniel J Moore